GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
SMS Pharmaceuticals Ltd

SMS Pharmaceuticals: Income Tax Appeal Dismissed, Rs. 7.19 Crore Demand Confirmed

REGULATORY ▼ Concern Flagged MEDIUM RISK
📅 Filed on BSE: 31 Oct 2026, 08:24 PM IST  ·  BSE ID: dada4d36-ea3f-4fb9-b561-3e56ea0be0c9
View Original BSE Filing (PDF)
💡
In Simple Terms
The tax department's appeal court rejected the company's challenge to a tax demand, confirming the assessment.
🤖 AI Summary
  • Income Tax Appeal dismissed by Commissioner of Income-tax (Appeals) for AY 2018-19.
  • Original demand was Rs. 7.19 Crores; reduced to Rs. 40.28 Lakhs via rectification.
  • Company's appeal against the assessment order has been dismissed by the appellate authority.
  • SMS Pharmaceuticals is assessing next steps after dismissal of its appeal.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Original Tax Demand (AY 2018-19)
Rs.7.19 Crores
Tax Demand after Rectification
Rs.40.28 Lakhs
Date of Appellate Order
30th October, 2026
Assessment Year
2018-19
🏢 How This Affects the Company
💰
Financial Impact
The dismissal of the appeal means the company must address the tax demand confirmed by the appellate order, potentially impacting its financial position if further legal recourse is unsuccessful or if the demand is enforced.
⚠️
Risk Impact
This increases the financial risk associated with the tax demand from the Income Tax Department, as the company's appeal has been dismissed.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders. Shareholders should monitor the company's updates on its review of the appellate order.
👤
Who Is Affected
All shareholders are affected by potential financial implications arising from the confirmed tax demand. The amount pertains to the Assessment Year 2018-19.
🔍
Management Signal
Management's intent to review the order indicates a process-driven approach to legal matters, prioritizing adherence to legal provisions.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Company's update on reviewing the appellate order.
Further legal actions or appeals filed by SMS Pharmaceuticals.
Income Tax Department's actions on the confirmed demand.
MEDIUM RISK Dismissal of appeal concerning a significant tax demand introduces financial and legal risk.
💡 Investor Takeaway
SMS Pharmaceuticals' appeal against a Rs. 7.19 Crores tax demand for AY 2018-19 has been dismissed by the Commissioner of Income-tax (Appeals). The company is assessing its next steps.
⚖️ Strengths & Concerns

⚠️ Concerns

  • Company's appeal against the Assessment Order for AY 2018-19 has been dismissed by the Commissioner of Income-tax (Appeals).
  • An original tax demand of Rs. 7.19 Crores has been sustained in appeal, despite a prior rectification reducing it to Rs. 40.28 Lakhs.
📅 Company Track Record
SMS Pharmaceuticals Ltd previously disclosed receipt of a Rs. 7.19 Crores income tax demand for FY 2018-19, which was later reduced to Rs. 40.28 Lakhs via a rectification order.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was the outcome of SMS Pharmaceuticals' appeal to the Income Tax Appellate Authority?
The Commissioner of Income Tax (Appeals) dismissed SMS Pharmaceuticals' appeal concerning the assessment order for Assessment Year 2018-19.
What was the original tax demand raised against SMS Pharmaceuticals for AY 2018-19?
The original demand notice was Rs. 7.19 Crores for the Assessment Year 2018-19.
Was the tax demand reduced before the appeal dismissal?
Yes, a rectification order reduced the tax demand to Rs. 40.28 Lakhs from Rs. 7.19 Crores.
When did SMS Pharmaceuticals receive the appellate order?
SMS Pharmaceuticals received the appellate order on 30th October, 2026.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.